Brain MRI findings in neurologically symptomatic COVID-19 patients: a systematic review and meta-analysis Amir Masoud AfsahiAlexander M. NorbashSam Sedaghat Review 03 August 2023 Pages: 5131 - 5154
Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis Lily DevlinGrace Y. Gombolay Review 15 August 2023 Pages: 5155 - 5161
Pitfalls and biases in neuroepidemiological studies of COVID-19 and the nervous system: a critical appraisal of the current evidence and future directions Ettore BeghiAndrei IvashynkaYun Jin Kim Review 08 September 2023 Pages: 5162 - 5170
Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review Chang GengWeili ZhaoHongzhi Guan Review 11 September 2023 Pages: 5171 - 5181
Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results Jonathan P. RogersMichael K. L. ChouMichael S. Zandi Short Commentary Open access 22 September 2023 Pages: 5182 - 5187
Practical recommendations on treatment of multiple sclerosis with Cladribine: an Israeli Experts Group Viewpoint Panayiota PetrouAnat AchironDimitrios Karussis Original Communication 12 July 2023 Pages: 5188 - 5195
Fingolimod-associated progressive multifocal leukoencephalopathy in a multiple sclerosis patient with a good response to filgrastim Paula Lombardo-del ToroIrene Bragado-TrigoLucía Romero-Pinel Letter to the Editors 17 July 2023 Pages: 5196 - 5200
Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR Samantha NoteboomD. R. van NederpeltM. M. Schoonheim Original Communication Open access 19 July 2023 Pages: 5201 - 5210
Multiple sclerosis lesions that impair memory map to a connected memory circuit Isaiah KletenikAlexander L. CohenMichael D. Fox Original Communication 02 August 2023 Pages: 5211 - 5222
Cortical thickness and cognition in older people with multiple sclerosis Dejan JakimovskiRobert ZivadinovRalph H. B. Benedict Original Communication 27 August 2023 Pages: 5223 - 5234
Sex-related differences in upper limb motor function in healthy subjects and multiple sclerosis patients: a multiparametric MRI study Raffaello BonacchiPaola ValsasinaMassimo Filippi Original Communication 28 August 2023 Pages: 5235 - 5250
Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions BaoLing ChenWanlin YangQing Wang Review 21 July 2023 Pages: 5251 - 5273
Role of expectations in clinical outcomes after deep brain stimulation in patients with Parkinson’s disease: a systematic review Francesca MameliEleonora ZironeFabiana Ruggiero Review Open access 30 July 2023 Pages: 5274 - 5287
Movement disorders in autoimmune encephalitis: an update Mengting QinJiaojiao ChenLing Mao Review 31 July 2023 Pages: 5288 - 5302
Acquired bilateral facial palsy: a systematic review on aetiologies and management Giulia MolinariDaniela LucidiMatteo Alicandri-Ciufelli Review Open access 31 July 2023 Pages: 5303 - 5312
Machine learning for adaptive deep brain stimulation in Parkinson’s disease: closing the loop Andreia M. OliveiraLuis CoelhoPaulo Aguiar Review Open access 02 August 2023 Pages: 5313 - 5326
The effects of exercise dose on patients with Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials Wenlai CuiDong LiJun Xie Review 02 August 2023 Pages: 5327 - 5343
Retrospective observational study on the use of acetyl-l-carnitine in ALS Serena SassiElisa BianchiElisabetta Pupillo Original Communication Open access 28 June 2023 Pages: 5344 - 5357
Correction to: Retrospective observational study on the use of acetyl-l-carnitine in ALS Serena SassiElisa BianchiElisabetta Pupillo Correction Open access 08 September 2023 Pages: 5358 - 5359
Neural patterns of conscious visual awareness in the Riddoch syndrome Ahmad BeyhSamuel E. RascheSemir Zeki Original Communication Open access 10 July 2023 Pages: 5360 - 5371
Efficacy of cerebellar transcranial magnetic stimulation in spinocerebellar ataxia type 3: a randomized, single-blinded, controlled trial Yuting ShiGuangdong ZouHong Jiang Original Communication 11 July 2023 Pages: 5372 - 5379
Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death Yukiko HataShojiro IchimataNaoki Nishida Original Communication 11 July 2023 Pages: 5380 - 5391
Cerebral lesions sites in neurosarcoidosis: a lesion mapping study Kilian FröhlichAnne MrochenKlemens Winder Original Communication Open access 12 July 2023 Pages: 5392 - 5397
Evaluation of myotonometry for myotonia, muscle stiffness and elasticity in neuromuscular disorders Katharina LukasKristina GutschmidtStephan Wenninger Original Communication Open access 17 July 2023 Pages: 5398 - 5407
Measuring cognitive impairment and monitoring cognitive decline in Huntington’s disease: a comparison of assessment instruments Andrea Horta-BarbaSaul Martinez-Hortathe Cognitive Phenotype Working Group of the European Huntington’s Disease Network Original Communication Open access 18 July 2023 Pages: 5408 - 5417
Longitudinal changes in qualitative aspects of semantic fluency in presymptomatic and prodromal genetic frontotemporal dementia Lize C. JiskootEsther van den BergHarro Seelaar Original Communication Open access 18 July 2023 Pages: 5418 - 5435
Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study Fabrizio VernieriNicoletta BrunelliClaudia Altamura Original Communication 19 July 2023 Pages: 5436 - 5448
Disability in cerebellar ataxia syndromes is linked to cortical degeneration Julian ConradAnna HuppertPeter zu Eulenburg Original Communication Open access 22 July 2023 Pages: 5449 - 5460
Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease Yasuaki MizutaniReiko OhdakeHirohisa Watanabe Original Communication Open access 22 July 2023 Pages: 5461 - 5474
Presymptomatic geographical distribution of ALS patients suggests the involvement of environmental factors in the disease pathogenesis Rosario VastaS. CallegaroA. Calvo Original Communication Open access 25 July 2023 Pages: 5475 - 5482
Inclusion body myositis with early onset: a population-based study Ulrika LindgrenCarola Hedberg-OldforsAnders Oldfors Original Communication Open access 27 July 2023 Pages: 5483 - 5492
Pre-treatment risk markers for hemorrhagic transformation in posterior circulation acute ischemic stroke treated with reperfusion therapy Claire AnceletSophie NeveüChristian Denier Original Communication 29 July 2023 Pages: 5493 - 5501
Differentiating between common PSP phenotypes using structural MRI: a machine learning study Andrea QuattroneAlessia SaricaAldo Quattrone Original Communication Open access 29 July 2023 Pages: 5502 - 5515
Prognosis of vestibular dysfunction in idiopathic sudden sensorineural hearing loss with vertigo: a prospective cohort study Weiming HaoLei YeHuawei Li Original Communication 30 July 2023 Pages: 5516 - 5526
Characteristics of primary Sjögren’s syndrome-associated peripheral nervous system lesions Jiaman ZhengJiayu ZhangChao Yuan Original Communication 31 July 2023 Pages: 5527 - 5535
The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank Eugene LinPo-Hsiu KuoShih-Jen Tsai Original Communication 01 August 2023 Pages: 5536 - 5544
Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease Julian TheurietFlorent CluseAntoine Pegat Original Communication Open access 04 August 2023 Pages: 5545 - 5560
Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease Marta BellofattoLuca Gentilefor the Italian C. M. T. Network Original Communication Open access 04 August 2023 Pages: 5561 - 5568
Correction to: Daytime sleepiness and sleep quality in Charcot–Marie–Tooth disease Marta BellofattoLuca Gentilefor the Italian C. M. T. Network Correction Open access 21 September 2023 Pages: 5569 - 5570
Clinical features and recovery pattern of secondary hypokalaemic paralysis Akiyuki HiragaKazuho KojimaSatoshi Kuwabara Original Communication 04 August 2023 Pages: 5571 - 5577
Left ventricular hypertrophy and left atrial size are associated with ischemic strokes among non-vitamin K antagonist oral anticoagulant users Alvin S. DasElif GökçalM. Edip Gurol Original Communication 07 August 2023 Pages: 5578 - 5588
Anxiety and physical impairment in patients with central vestibular disorders Lena PadovanSandra Becker-BenseMarianne Dieterich Original Communication Open access 08 August 2023 Pages: 5589 - 5599
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) Massimo FilippiRoberta MessinaRESET BRAIN Study Group Original Communication Open access 08 August 2023 Pages: 5600 - 5612
Combined measure of salivary alpha-synuclein species as diagnostic biomarker for Parkinson’s disease Fabrizio AngiusIgnazia MocciAnna R. Carta Short Commentary Open access 08 August 2023 Pages: 5613 - 5621
Susceptibility to brain ischemia and the association between migraine and spontaneous cervical artery dissection Elisabetta Del ZottoMario GrassiThe Italian Project on Stroke in Young Adults—Cervical Artery Dissection (IPSYS CeAD) Research Group Letter to the Editors 12 July 2023 Pages: 5622 - 5628
4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience Jens SeemannAndreas TraschützMatthis Synofzik Letter to the Editors Open access 13 July 2023 Pages: 5629 - 5634
Menière’s disease with migraine, Menière’s disease without migraine and Vestibular migraine: clinical differences Gülden AkdalTural TanrıverdizadeGünay Kırkım Letter to the Editors 15 July 2023 Pages: 5635 - 5638
Crossing the border between epileptic and vascular pathology: a report of CACNA1A-related treatment-resistant hemiplegic migraine M. RubinG. CutilloB. Colombo Letter to the Editors 19 July 2023 Pages: 5639 - 5644
Typewriter tinnitus with time-locked vestibular paroxysmia in a patient with cerebellopontine angle meningioma Yuzhong ZhangMarcus L. F. JanssenRaymond van de Berg Letter to the Editors Open access 21 July 2023 Pages: 5645 - 5648
Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects Benjamin RoebenMadeleine ScharfMatthis Synofzik Letter to the Editors Open access 28 July 2023 Pages: 5649 - 5654